Lamotrigine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 67046-0749
  • Package NDC 67046-0749-3
  • Application number ANDA090170
  • SPL ID 545fcb8e-1f7a-c2f7-e063-6394a90a004d
  • SPL set ID 545fcc0e-1e2b-bdcb-e063-6294a90a4ac7
  • UNII U3H27498KS
  • RxCUI 198428

What the source publishes

Labeler
Coupler LLC
Active ingredients
Lamotrigine
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:67046-0749_545fcb8e-1f7a-c2f7-e063-6394a90a004d
{
  "name": "Lamotrigine",
  "splId": "545fcb8e-1f7a-c2f7-e063-6394a90a004d",
  "labels": [
    {
      "setId": "545fcc0e-1e2b-bdcb-e063-6294a90a4ac7",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=545fcc0e-1e2b-bdcb-e063-6294a90a4ac7",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=545fcc0e-1e2b-bdcb-e063-6294a90a4ac7"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Coupler LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BLISTER PACK (67046-0749-3)",
      "package_ndc": "67046-0749-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260616"
    }
  ],
  "productId": "67046-0749_545fcb8e-1f7a-c2f7-e063-6394a90a004d",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "67046-0749",
  "deaSchedule": null,
  "genericName": "Lamotrigine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LAMOTRIGINE",
      "strength": "150 mg/1"
    }
  ],
  "applicationNumber": "ANDA090170",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260616",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175753",
      "N0000008486",
      "N0000175751",
      "N0000187061",
      "N0000000191"
    ],
    "unii": [
      "U3H27498KS"
    ],
    "rxcui": [
      "198428"
    ],
    "spl_set_id": [
      "545fcc0e-1e2b-bdcb-e063-6294a90a4ac7"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
      "Anti-epileptic Agent [EPC]",
      "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
      "Organic Cation Transporter 2 Inhibitors [MoA]",
      "Dihydrofolate Reductase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Coupler LLC"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:67046-0749_545fcb8e-1f7a-c2f7-e063-6394a90a004d"